Clinical Study to Evaluate Effect of Shampoo in Subjects With Hair Loss. (NCT07433933) | Clinical Trial Compass
CompletedNot Applicable
Clinical Study to Evaluate Effect of Shampoo in Subjects With Hair Loss.
Spain40 participantsStarted 2025-05-12
Plain-language summary
The goal of this observational study is to learn about the effects of anti-hair loss shampoo in subjects over the age of 18 who use shampoo to treat their hair loss caused by telogen effluvium (TE) and androgenetic alopecia (AGA). The main question it aims to answer is:
ā¢ Does a shampoo use help to reduce the visible signs of hair loss related to TE and AGA?
Subjects will use the shampoo for 3 months and visit the clinic for the visits established by the protocol.
Who can participate
Age range18 Years ā 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Sex: Both (50% women; 50% men).
* Age: 18-65 years.
* Subjects with hair loss due to telogen effluvium or mild or incipient androgenic alopecia, in an 80/20 ratio.
* Degree of androgenic alopecia: Ludwig scale score I-II for women and Hamilton-Norwood scale score III-II for men.
* Telogen effluvium: Combing test.
* Subjects with all hair types (oily, combination, sensitive, etc.).
* Subjects with all scalp types (normal, sensitive, etc.).
* Agree to participate voluntarily in the study and provide written informed consent.
* Adequate level of understanding of the clinical study.
* Good health (physical and mental).
* Availability to attend visits to the research centres.
* No application of any product to the experimental area on the first day of the trial.
Exclusion Criteria:
* Individuals under 18 years of age.
* Pregnant or breastfeeding women.
* Injuries or infection in the test area.
* History of allergies to cosmetic products.
* Known allergies to product components.
* Sensitivity to any product component.
* Patients who have undergone recent surgery or treatments in the study area.
* Cancer patients.
* Volunteers currently taking antibiotics, antihistamines, corticosteroids, beta-blockers, retinoids, azelaic acid, or acne therapies, or whose treatment ended within 15 days prior to the start of the study. Participation in another clinical study.
* Use of or having used cosmetic products and/or oral or topical treatments for hair loss for at leasā¦
What they're measuring
1
Change in hair lenght and thickness
Timeframe: From baseline to the end of use at 3 months.